Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Archerfish has commercialized advanced molecular diagnostic assays for cancer screening and infectious disease detection. The company leverages NGS—including mNGS—for comprehensive pathogen identification from plasma samples. It also utilizes aptamer-based serum proteomics to profile thousands of proteins for early disease detection. Artificial intelligence enhances data analysis and predictive accuracy. Clinical results are not detailed but the company builds on Angsana’s track record of successful test commercialization in Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Archerfish Precision Diagnostics.